• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Incyte Corporation - Common Stock (NQ:INCY)

    116.08 -1.06 (-0.91%)
    Delayed Quote Updated: 12:11 PM EDT, Oct 2, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 544,840
    Open 116.76
    Bid (Size) 115.99 (100)
    Ask (Size) 116.16 (100)
    Prev. Close 117.14
    Today's Range 115.17 - 117.19
    52wk Range 82.81 - 132.60
    Shares Outstanding 222,430,635
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Q2 Earnings Roundup: Incyte (NASDAQ:INCY) And The Rest Of The Biotechnology Segment
    The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how biotechnology stocks f... 
    Via StockStory
    Topics Artificial Intelligence
    Incyte (NASDAQ:INCY) Combines High Growth Momentum With a Breakout Setup ↗
    Via Chartmill

    Performance

    52-Week Range 12.5% below 52-week high
    116.08
    82.8152W Low 132.6052W High
    1 Week 8.0% below 1-week high
    117.001W Low 126.141W High

    Incyte Corporation - Common Stock (INCY) traded between $82.81 and $132.60 over the past 52 weeks and last traded at $116.08, 12.5% below its 52-week high. Over the past week it ranged between $117.00 and $126.14.

    Past 12 Months
    -6.3%
    -7.1%
    -0.7%
    +21.0%
    +14.4%
    +33.9%
    1W -$7.81
    1M -$8.94
    3M -$0.78
    6M +$20.14
    YTD +$14.66
    1Y +$29.38

    INCY was +33.9% over the past year, +21.0% over six months, +14.4% year to date, -6.3% in the last week.

    12 Months vs Market
    INCY
    +33.9%
    DIA
    +9.9%
    SPY
    +15.2%
    QQQ
    +24.5%
    IWM
    +16.2%

    Over the past 12 months INCY returned +33.9% versus DIA (Dow) +9.9%, SPY (S&P 500) +15.2%, QQQ (Nasdaq 100) +24.5% and IWM (Russell 2000) +16.2%.

    Volume & Liquidity 0.34× 3-mo avg
    Today 544,840 3-mo avg 1.6M
    1W
    1.7M
    1M
    1.6M
    3M
    1.6M
    6M
    1.6M
    YTD
    1.7M
    1Y
    1.8M

    INCY most recently traded 544,840 shares against a 3-month average daily volume of 1.6M.

    More News

    Read More
    News headline image
    Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz™ (zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva
    From Mirum Pharmaceuticals, Inc. and Incyte
    Via Business Wire
    Discover the top S&P500 movers in Tuesday's pre-market session. ↗
    Via Chartmill
    News headline image
    Incyte Data at the European Academy of Dermatology and Venereology (EADV) Congress Underscore the Breadth of Incyte’s Inflammation and Autoimmunity Portfolio
    From Incyte
    Via Business Wire
    Incyte (NASDAQ:INCY) Combines Minervini Trend Template Strength With High-Growth Momentum ↗
    Via Chartmill
    Incyte (NASDAQ:INCY) Combines High Growth Momentum with a Breakout Setup ↗
    Via Chartmill
    Incyte (NASDAQ:INCY) Passes Minervini Trend and High-Growth Screens, But Setup Demands Patience ↗
    Via Chartmill
    News headline image
    Incyte Maps Post-JAKAFI Growth With Pipeline Push and $4B Sales Target ↗
    Via MarketBeat
    News headline image
    3 Growth Stocks to Add to Your Roster
    Via StockStory
    Topics Economy
    News headline image
    1 Cash-Heavy Stock for Long-Term Investors and 2 We Ignore
    Via StockStory
    Topics Credit Cards
    News headline image
    Incyte (INCY): 3 Reasons We Love This Stock
    Via StockStory
    Topics Artificial Intelligence Stocks
    Incyte (NASDAQ:INCY) Combines High Growth Momentum with a Breakout Setup ↗
    Via Chartmill
    News headline image
    Here's How Much $1000 Invested In Incyte 20 Years Ago Would Be Worth Today ↗
    Via Benzinga
    News headline image
    2 Cash-Producing Stocks with Promising Prospects and 1 We Brush Off
    Via StockStory
    News headline image
    3 Market-Beating Stocks with Competitive Advantages
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    News headline image
    2 Profitable Stocks with Impressive Fundamentals and 1 We Brush Off
    Via StockStory
    News headline image
    Incyte to Present at Upcoming Investor Conferences
    From Incyte
    Via Business Wire
    News headline image
    Here’s How Much You Would Have Made Owning Incyte Stock In The Last 20 Years ↗
    Via Benzinga
    News headline image
    Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Incyte Corporation
    Via Business Wire
    News headline image
    1 Unpopular Stock That Deserves Some Love and 2 Facing Headwinds
    Via StockStory
    Topics Supply Chain
    News headline image
    Opzelura® (ruxolitinib) Cream Becomes First Steroid-Free Topical JAK Inhibitor Approved in the European Union for Adults with Moderate Atopic Dermatitis
    From Incyte
    Via Business Wire
    Exploring the top movers within the S&P500 index during today's session. ↗
    Via Chartmill
    Curious about which S&P500 stocks are generating unusual volume on Tuesday? Find out below. ↗
    Via Chartmill
    News headline image
    Incyte Q2 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings

    Frequently Asked Questions

    Is Incyte Corporation - Common Stock publicly traded?
    Yes, Incyte Corporation - Common Stock is publicly traded.
    What exchange does Incyte Corporation - Common Stock trade on?
    Incyte Corporation - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Incyte Corporation - Common Stock?
    The ticker symbol for Incyte Corporation - Common Stock is INCY on the Nasdaq Stock Market
    What is the current price of Incyte Corporation - Common Stock?
    The current price of Incyte Corporation - Common Stock is 116.08
    When was Incyte Corporation - Common Stock last traded?
    The last trade of Incyte Corporation - Common Stock was at 10/02/26 12:11 PM ET
    What is the market capitalization of Incyte Corporation - Common Stock?
    The market capitalization of Incyte Corporation - Common Stock is 25.82B
    How many shares of Incyte Corporation - Common Stock are outstanding?
    Incyte Corporation - Common Stock has 26B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.